Press release
Cluster Headaches Therapeutics Market Size in the 7MM was ~USD 890 million in 2023, is estimated to increase by 2034 | DelveInsight
DelveInsight's "Cluster Headaches Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Cluster Headaches, historical and forecasted epidemiology as well as the Cluster Headaches market trends in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.Discover Key Insights into the Cluster Headaches Market with DelveInsight's In-Depth Report @ Cluster Headaches Market Size [https://www.delveinsight.com/sample-request/cluster-headache-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Cluster Headaches Market Report
* In November 2024:- Salvia BioElectronics- The purpose of this study is to demonstrate the safe use of the PRIMUS System in subjects with chronic cluster headache. This is a single-centre, open label, prospective, first in human study to collect initial clinical data on the PRIMUS system for the treatment of chronic cluster headache.
* Among EU4 and the UK, Germany had the highest prevalent cases of Cluster Headaches, with 98 thousand cases and Spain had the lowest cases which were 62 thousand, in 2023.
* According to DelveInsight's estimates, the type-specific cases of cluster headaches in the US were categorized into episodic and chronic forms. In 2023, the episodic type accounted for the majority of cases, with 162 thousand, compared to 41 thousand cases of the chronic type.
* Based on Gender-specific instances, there were 41 thousand males and 17.7 thousand females affected by Cluster Headaches in Germany in 2023.
* In Japan, based on age, the prevalent cases of Cluster Headaches were categorized into two groups: Below 18 and 18 and above age group, from which 18 and above accounted for the highest number of cases, approximately 72 thousand in 2023.
* The leading Cluster Headaches Companies such as Novartis AG, Zosano Pharma, Eli Lily and Company, AstraZeneca Plc., Autonomic Technologies, Inc, ElectroCore Medical LLC, GlaxoSmithKline Plc, Winston Pharmaceuticals Inc, Lundback Seattle BioPharmaceutical , and others
* Promising Cluster Headaches Therapies such as VYEPTI (Eptinezumab), Civamide (Zucapsaicin), Zolmitriptan transdermal , and others
Stay ahead in the Cluster Headaches Therapeutics Market with DelveInsight's Strategic Report @ Cluster Headaches Market Outlook [https://www.delveinsight.com/sample-request/cluster-headache-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Cluster Headaches Epidemiology Segmentation in the 7MM
* Total Cluster Headaches Prevalence Cases
* Cluster Headaches Diagnosed Cases
* Cluster Headaches Type-specific Cases
* Cluster Headaches Gender-specific Cases
* Cluster Headaches Age-specific Cases
Download the report to understand which factors are driving Cluster Headaches epidemiology trends @ Cluster Headaches Prevalence [https://www.delveinsight.com/sample-request/cluster-headache-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Cluster Headaches Marketed Drugs
* EMGALITY (Galcanezumab-gnlm): Eli Lilly and Company
EMGALITY (galcanezumab-gnlm) is a humanized IgG4 monoclonal antibody that binds to the calcitonin gene-related peptide (CGRP) ligand and blocks its interaction with the receptor. It is formulated as a sterile, preservative-free solution for subcutaneous injection, with a molecular weight of approximately 147 kDa. Approved by the US FDA in June 2019 for treating episodic cluster headaches in adults, EMGALITY is the first CGRP antibody to receive such approval. It was initially approved in September 2018 for migraine prevention and has also been approved in the European Union for migraine prophylaxis. In March 2019, the FDA granted Priority Review and Breakthrough Therapy Designation for its use in episodic cluster headaches.
Cluster Headaches Emerging Drugs
* VYEPTI (Eptinezumab): Lundbeck Seattle BioPharmaceutical
Eptinezumab is a monoclonal immunoglobulin G1 (IgG1) antibody that exhibits high specificity and affinity for both the - and -forms of human calcitonin gene-related peptide (CGRP). CGRP plays a critical role in the pathophysiology of migraine and cluster headaches by modulating neurogenic inflammation. Eptinezumab is currently in Phase III development, with recent advancements focusing on its efficacy and safety profile. The latest data highlights its potential to provide significant relief for cluster headache sufferers, with ongoing trials aimed at further validating its therapeutic benefit and optimizing its clinical application.
Cluster Headaches Market Outlook
Cluster headache treatment involves acute and preventive phases. Acute treatments include triptans (sumatriptan, zolmitriptan), high-flow oxygen, somatostatin, and its analogs, with triptans being the most commonly used. Analgesics like lidocaine and dihydroergotamine are additional options, while opioids and NSAIDs are not recommended due to questionable efficacy. Preventive therapy includes maintenance and transitional prophylaxis. Verapamil is the primary maintenance medication, valued for its safety and effectiveness. Corticosteroids, such as methylprednisolone, provide rapid control at treatment onset, while transitional prophylaxis supports maintenance therapy. Other options include methysergide, melatonin, and gabapentin, although methysergide is not available in the USA.
Get In-Depth Knowledge on Cluster Headaches Market Trends and Forecasts with DelveInsight @ Cluster Headaches Treatment Market [https://www.delveinsight.com/sample-request/cluster-headache-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Cluster Headaches Market Report
* Study Period: 2020-2034
* Coverage: 7MM
* Cluster Headaches Companies: Dana-Farber Cancer Institute, Huabo Biopharm Co., Ltd., Beijing Scitech-Mq Pharmaceuticals, Oxford BioMedica, Hutchison Medipharma Limited, Takeda, Amgen, Novartis, AVEO Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, SCRI Development Innovations, LLC, Astellas Pharma Inc, and others
* Cluster Headaches Therapies: VYEPTI (Eptinezumab), Civamide (Zucapsaicin), Zolmitriptan transdermal, and others
* Cluster Headaches Therapeutic Assessment: Cluster Headaches current marketed and Cluster Headaches emerging therapies
* Cluster Headaches Market Dynamics: Cluster Headaches market drivers and Cluster Headaches market barriers
* Cluster Headaches Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Cluster Headaches Unmet Needs, KOL's views, Analyst's views, Cluster Headaches Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Cluster Headaches Market Report @ Cluster Headaches Market Drivers and Barriers [https://www.delveinsight.com/sample-request/cluster-headache-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1 Key Insights
2 Report Introduction
3 Cluster Headache Market Overview at a Glance
4 Cluster Headache Executive Summary
5 Cluster Headache Key Events
6 Disease Background and Overview: Cluster Headache
7 Cluster Headache Epidemiology and Patient Population
8 Cluster Headache Patient Journey
9 Cluster Headache Emerging Therapies
10 Cluster Headache: Seven Major Market Analysis
11 Cluster Headache Unmet Needs
12 SWOT Analysis
13 Cluster Headache Market Access and Reimbursement
14 Appendix
15 Bibliography
16 Disclaimer
17 About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cluster-headaches-therapeutics-market-size-in-the-7mm-was-usd-890-million-in-2023-is-estimated-to-increase-by-2034-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cluster Headaches Therapeutics Market Size in the 7MM was ~USD 890 million in 2023, is estimated to increase by 2034 | DelveInsight here
News-ID: 3772033 • Views: …
More Releases from ABNewswire

Arizona Balloon Company Releases 2025 Buyer's Guide to Advertising Blimps
Arizona Balloons Registered has released its 2025 Buyer's Guide to Advertising Blimps, a practical resource for marketing managers and procurement teams evaluating materials, safety practices, and total cost of ownership. The guide outlines key decision points-polyurethane vs. PVC, size selection for different sites, helium and staffing considerations, wind thresholds, and warranty terms-so buyers can compare vendors on more than just upfront price. For organizations planning to buy advertising blimps.
Why a…

Thoughts & Healing Prayers for Recovery from Addiction: How to Know God Intimate …
Award-winning authorMelissa A. Phoenix chronicles her descent into darkness and her subsequent recovery and redemption by releasing her book, Thoughts & Healing Prayers for Recovery from Addiction: How to Know God Intimately [https://www.amazon.ca/dp/1772776084].
Melissa is blunt, transparent, and doesn't ask for your understanding. Instead, she describes her experience and explains her thoughts and conclusions while offering you the chance to adapt and apply what has worked for her to your own…

HighJoule Releases 2025 Guide on How Many Solar Panels Needed to Power a House
Image: https://www.abnewswire.com/upload/2025/08/97bba235dc34dfb2a68dd164b66576ec.jpg
Introduction
2025, like, every year, is witness o an increasing demand for clean energy. Today the question in many homeowners' mouths is how many solar panels is necessary to power a house in today's world? The question doesn't have a single answer, because energy consumption will vary by house size, family lifestyle and type of solar panels installed. Changing technology For example, in 2025, panels are a lot more efficient,…

The Core Collab Launches the Sculptformer as a Megaformer Alternative
The boutique fitness brand introduces a high-performance machine that rivals elite reformers at a more accessible price point.
Image: https://www.abnewswire.com/upload/2025/08/3000f40b17c64921f46b6e108dda7b7c.jpg
California, United States - August 29, 2025 - The Core Collab, a boutique fitness brand with studios in both the United States and Australia, is reshaping the conversation around high-intensity Pilates with its latest innovation: the Sculptformer. Designed to rival the Megaformer and other elite training machines, the Sculptformer delivers the same…
More Releases for Cluster
Global Cluster Munitions Market Size by Application, Type, and Geography: Foreca …
According to Market Research Intellect, the global Cluster Munitions market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Ongoing geopolitical tensions, military arsenal upgrading, and regional wars are driving slow expansion of the cluster munitions business. Some…
Global Automotive Instrument Cluster Market
All of the top selling models in Europe feature hybrid instrument cluster.
The 2 wheelers are sold in high numbers in Asia region, account for a sizeable instrument cluster market volume in the region.
The digital instrument cluster market accounts for a small share of the market but has been growing at the fastest rate,especially in China.
VW now offers biggest range of Digital instrument cluster starting from Polo, Golf, to…
Instrument Cluster Market | Robert Bosch GmbH, launched the world’s first curv …
A clear and precise display of information is vital for the driver to ensure a safe and comfortable ride. The different types of instrument clusters have been witnessing increasing traction in the automobile sector, as they provide attractive and accurate information to keep the driver vigilant while driving. Instrument cluster is a driver information system that combines vital details, such as vehicle speed, traffic condition, and amount of fuel available,…
Boise State University Reduces HPC Cluster Operating Costs with Bright Cluster M …
University found Bright Cluster Manager to be less expensive than open source HPC cluster management tool-kits
Bright Computing announced today that Boise State University researchers selected Bright Cluster Manager® for their collaboration research cluster R1, a powerful computer system that drives interdisciplinary computational research. Boise State University research projects span chemistry, biology, physics and pharmacology, with particular emphasis on advancing novel methods in molecular targeted therapeutics for cancer research. Bright Cluster…
Bright Cluster Manager Selected For HPC Cluster Research Grant at St. Louis Univ …
Bright Computing today announced that Bright Cluster Manager® 6.0 was selected as part of an HPC cluster research grant awarded to St. Louis University (SLU). The university is the winner of a high-performance computer cluster donated by Silicon Mechanics, and its vendor partners Bright Computing, AMD, Kingston Technologies, NVIDIA, QLogic, Supermicro and Seagate.
Bright Cluster Manager is increasingly the solution of choice for academic institutions looking to minimize system management…
Bright Cluster Manager chosen for TOP500-class HPC Cluster in France
Consortium led by the University of Bordeaux 1 and including leading universities, research institutes in southwest France purchase 3,168-core supercomputer comprising technology from Dell, Intel and Bright Computing
San Jose, California — Bright Computing, a leader in cluster management software, announced today that the company has been selected to provide the cluster management solution for a French research consortium’s new supercomputer. The HPC cluster, to be installed by ClusterVision at…